Pfizer (PFE) May Apply For Approval of its Vaccine in Russia

According to Pfizer (PFE) press office, the company may apply for government approval of its vaccine against Covid-19 in Russia, the Tass agency reported.

Specifically, Pfizer hopes to develop a vaccine distributed to world governments and international organizations, so the sections of the most vulnerable population could get this vaccine according to these recommendations and within a short period after receiving approval from the international organizations and local regulatory authorities. The company is considering applying for approval of the Covid-19 vaccine to the Russian Federation.

Furthermore, the company asserted that Pfizer (PFE) and BioNTech are cooperating to ensure that the vaccine meets a global public health system’s needs.

Earlier yesterday, the Russian news agency Interfax reported that Pfizer would only market its vaccine in countries with signed government-level agreements, and the Russian Federation has yet to sign such agreements.

The pharmaceutical company Pfizer (PFE) announced in another press release that it had invested $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI) in the second half of 2020. Pfizer is making a significant commitment to biotechnology companies, as part of PBGI, to provide funding and access to Pfizer’s scientific expertise to help ensure advanced clinical research and development programs will succeed.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Pfizer Inc. (PFE) shares were reported down -1.56% in trading on Tuesday. At $37.18 per share, Pfizer shares have gained 1.01% year to date. The market capitalization of Pfizer Inc. (PFE) is $206.33 billion at the time of writing. During the past month, the average daily volume for PFE was 40814484 shares, which is lower than its average daily volume over the past year by 25.66, suggesting a greater level of market activity in this company lately.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Recent Articles

COVID-19 Testing Frequency Is Unlikely To Decline And Abbott Labs (ABT) Is Main Beneficiary

The stock of Abbott Labs (ABT) has gained almost 40% over the past year. Sales of COVID-19 tests for the ABT stock were strong,...

What is behind this recent momentum of Ebix Inc. (NASDAQ: EBIX)

Despite the decline in February, Ebix Inc. (EBIX) gained double-digits in March, partially recovering from the drop. EBIX was trading at $ 31.06 on...

General Motors (GM) To Invest Almost $30 Billion in EV’s

For the first time in its history, General Motors (GM) plans on investing around $30 billion into electric vehicle development and production. Many investors...

The Fundamentals Of Designer Brands Inc. (DBI) Are A Compelling Reason To Be Bullish On The Stock

Some investors were pleased to see that the DBI stock's executives that sells high-end footwear, Designer Brands Inc(DBI), acquired new shares of their company...

The Fundamental Case for and Against Sage Therapeutics (SAGE)

During the past 52 weeks, Sage Therapeutics (SAGE) shares have fallen about 25%. Another reason for the decline in quotations is the drug's inability...

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.